Page 1 of 1INSTRUCTIONS: Please type or print in ink. Please read carefully the attached instructions and supply the information requested on this form.Use additional sheet(s) if necessary.1. Company Name and Address4. EPA ProductRegistrationOMB Approval 2070-174United States Environmental ProtectionAgency Washington, D.C. 20460DATA CALL-IN RESPONSE3. Date and Type of DCI and NumberGENERIC22-Sep-2011ID # GDCI-022003-302272. Case # and Name0139 Coal Tar/CreosoteChemical # and Name022003Coal tar5. I wish tocancel thisproduct registration voluntarily6. Generic Data7. Product Specific Data7a. My product is an MUP andI agree to satisfy the MUPrequirements on the attachedform entitled "RequirementsStatus and Registrant'sResponse."7b. My product is an EUP andI agree to satisfy the EUPrequirements on the attachedform entitled "RequirementsStatus and Registrant'sResponse."6a. I am claiming a GenericData Exemption because Iobtain the active ingredientfrom the source EPA registration number listed below.6b. I agree to satisfy GenericData requirements as indicatedon the attached form entitled"Requirements Status andRegistrant's Response."N.A.N.A.10. Name of Company11. Phone Number9. Date8. Certification I certify that the statements made on this form and all attachments are true, accurate, and complete. I acknowledge that anyknowingly false or misleading statement may be punishable by fine, imprisonment or both under applicable law.Signature and Title of Company's Authorized Representative__________________________________Coal tarINSTRUCTIONS: Please type or print in ink. Please read carefully the attached instructions and supply the information requested on this form.Use additional sheet(s) if necessary.4. GuidelineRequirementNumber5. Study Title1. Company Name and AddressPage 1 of 1OMB Approval 2070-174United States Environmental ProtectionAgency Washington, D.C. 20460REQUIREMENTS STATUS AND REGISTRANT'S RESPONSE3. Date and Type of DCI and NumberID #GENERIC22-Sep-2011GDCI-022003-302272. Case # and Name0139 Coal Tar/Creosote022003Chemical # and Name8. TimeFrame(Months)9. RegistrantResponse7. TestSubstance6. UsePatternPROTOCOLProgressReports321Applicator Exposure Data Requirements (Antimicrobial)(14 ,16)875.110024BBDermal exposure--outdoor(2 ,17)875.120024BBDermal exposure--Indoor(7 ,8 ,9 ,18)875.130024BBInhalation exposure--outdoor(4 ,19)875.140024BBInhalation exposure--indoor(10 ,15)875.160012BBApplication exposure monitoring data reporting(3)875.170012BBProduct Use InformationEnvironmental Fate Data Requirements (Antimicrobial)(5 ,11 ,12 ,13,20)SS-Leaching12BBLeaching study(1 ,6)SS-SedimentConc24BBSediment concentration, Aquatic structures12. Name of Company13. Phone NumberSignature and Title of Company's Authorized Representative__________________________________10. Certification I certify that the statements made on this form and all attachments are true, accurate, and complete. Iacknowledge that anyknowingly false or misleading statement may be punishable by fine, imprisonment or both under applicable law11. DateCase # and Name:0139 Coal Tar/CreosoteDCI Number:GDCI-022003-30227Page 1 of 2[The following notes are referenced in column two (5. Study File) of the REQUIREMENTS STATUS AND REGISTRANT'S RESPONSE form.]Footnotes:Key:United States Environmental ProtectionAgency Washington, D.C. 20460FOOTNOTES AND KEY DEFINITIONS FOR GUIDELINE REQUIREMENTSUse Categories Key:BB - Wood preservatives1Please see 40 CFR Sections 158 and/or 161 for additional information.2Please see 40 CFR Sections 158 and/or 161 for additional information.3Please see 40 CFR Sections 158 and/or 161 for additional information.4Please see 40 CFR Sections 158 and/or 161 for additional information.5Please see 40 CFR Sections 158 and/or 161 for additional information.6Field study or simulated study for aquatic structures, sediment concentration data for warm southern conditions, and water column concentrations from microcosm studies. Data collected innorthern conditions cannot be used to satisfy this requirement. A protocol must be submitted for review and approval by the Agency prior to initiating this study. The draft protocol must besubmitted to the Agency within 90 days of receipt of this DCI.7The Agency will require application exposure data beyond the required product use information (Guideline 875.1700) if at leastone of the following exposure criteria and at least one of thefollowing toxicity criteria are met by the TEP, TGAI, or one of the pesticide's metabolites: (i) Exposure criteria. (A) Dermalexposure is likely to occur during use. (B) Inhalation exposure is likelyto occur during use. (C) Adequate surrogate exposure data (e.g. PHED) to estimate the magnitude of exposure for a particular work activity with an acceptable degree of confidence areunavailable. (ii) Toxicity criteria. (A) The acute dermal LD50 is less than or equal to 200 mg/kg (i.e., Toxicity CategoryI (Guideline 870.1200) as per 40 CFR 156.10). (B) The acute inhalationLC50 (Guideline 870.1300) is less than or equal to 0.05 mg/liter (i.e., 4-hour exposure, Toxicity Category I) and the TGAI hasa vapor pressure greater than 10-3 mm Hg at 25degrees C if usedoutdoors or any indoor application regardless of the vapor pressure. (C) The pesticide is found to be a neurotoxicant (Guideline 870.6200). (D) The pesticide is found to be a developmentaltoxicant (Guidelines 870.3700 and 870.6300). (E) The pesticide is found to be a carcinogen (Guideline 870.4200). (F) The pesticide shows potential adverse effects in subchronic studies suchas 90-day oral (Guideline 870.3100), 21-day repeated dermal toxicity (Guideline 870.3200), 90-day dermal toxicity (Guideline 870.3250), 90-day inhalation (Guideline 870.3465), reproductionand fertility effects (Guideline 870.3800), and chronic feeding (Guideline 870.4100). (G) The pesticide is found to be a mutagen (Guidelines 870.5100 to 870.5900) or an immunotoxicant(Guideline 870.7800). (H) Epidemiological or poisoning incidence data indicate adverse effects from handling the pesticide.8Required for outdoor uses when that is the primary use or if outdoor uses are expected to result in greater exposure than indoor uses.9Protocols must be submitted to the Agency for approval before initiating a study.10Data reporting and calculations are required when exposure data are submitted.11Sterile buffered distilled water and sterile synthetic seawater must be used for the antifoulant hydrolysis and leaching studies.Case # and Name:0139 Coal Tar/CreosoteDCI Number:GDCI-022003-30227Page 2 of 2[The following notes are referenced in column two (5. Study File) of the REQUIREMENTS STATUS AND REGISTRANT'S RESPONSE form.]Footnotes:Key:United States Environmental ProtectionAgency Washington, D.C. 20460FOOTNOTES AND KEY DEFINITIONS FOR GUIDELINE REQUIREMENTSUse Categories Key:BB - Wood preservatives12Data are required if exposure estimates from modeling (e.g., dilution factor model) indicate that active ingredient or principal transformation products are likely to be found in effluent discharge ornontarget waters and when any of the following conditions apply:(i) Modeling indicates acute Estimated Environmental Concentrations (EECs) of active ingredient or principal transformation products in the aquatic environment are greater than or equal to 0.5of any LC50/EC50 value determined in acute toxicity testing for aquatic vertebrates or invertebrates.(ii) Modeling indicates continuous, or chronic, Estimated Environmental Concentrations (EECs) of active ingredient or principal transformation products in the aquatic environment are greaterthan or equal to 0.01 of any LC50/EC50 value determined in acute toxicity testing for aquatic vertebrates or invertebrates.(iii) Physicochemical properties of the compound indicate cumulative effects may occur (e.g., Kow is greater than or equal to1,000).(iv) The active ingredient or principal transformation products are persistent in water (e.g., hydrolysis half-life in water is greater than 4 days).13Applicants must obtain approval of wood preservative leaching study protocols from the Agency prior to initiation of testing. The following methods or their equivalents will be accepted: for woodpreservatives, the American Wood Preservers= Association=s Standard Method of Determining the Leachability of Wood Preservatives (E11-97); for antifoulants, the ASTM Method D5190.14Please see 40 CFR Sections 158 and/or 161 for additional information.15In accordance with 40 CFR 158.1020, OPPTS Guideline 875.1600 is required to accompany OPPTS Guidelines 875.1100 (Dermal OutdoorExposure), 875.1200 (Dermal Indoor Exposure),875.1300 (Inhalation Outdoor Exposure), and 875.1400 (Inhalation Indoor Exposure). When all four GLNs are listed, the registrant is only required to perform two of the four tests, one dermalexposure and one inhalation exposure.16Prior to initiation of the study, protocols must be submitted for review and approval by the Agency. Studies involving intentional exposure of human subjects must be submitted for review byEPA and then the Human Studies Review Board (HSRB) according to 40 CFR 26.1125. Examples of proposed human study research can be found in various reviews provided by the HumanStudies Review Board (http://www.epa.gov/osa/hsrb/index.htm). The draft protocol must be submitted to the Agency within 90 days of receipt of this DCI.17Prior to initiation of the study, protocols must be submitted for review and approval by the Agency. Studies involving intentional exposure of human subjects must be submitted for review byEPA and then the Human Studies Review Board (HSRB) according to 40 CFR 26.1125. Examples of proposed human study research can be found in various reviews provided by the HumanStudies Review Board (http://www.epa.gov/osa/hsrb/index.htm). The draft protocol must be submitted to the Agency within 90 days of receipt of this DCI.18Prior to initiation of the study, protocols must be submitted for review and approval by the Agency. Studies involving intentional exposure of human subjects must be submitted for review byEPA and then the Human Studies Review Board (HSRB) according to 40 CFR 26.1125. Examples of proposed human study research can be found in various reviews provided by the HumanStudies Review Board (http://www.epa.gov/osa/hsrb/index.htm). The draft protocol must be submitted to the Agency within 90 days of receipt of this DCI.19Prior to initiation of the study, protocols must be submitted for review and approval by the Agency. Studies involving intentional exposure of human subjects must be submitted for review byEPA and then the Human Studies Review Board (HSRB) according to 40 CFR 26.1125. Examples of proposed human study research can be found in various reviews provided by the HumanStudies Review Board (http://www.epa.gov/osa/hsrb/index.htm). The draft protocol must be submitted to the Agency within 90 days of receipt of this DCI.20Aprotocol must be submitted for review and approval by the Agency prior to initiating this study. The draft protocol must be submitted to the Agency within 90 days of receipt of this DCI.United States Environmental ProtectionAgency Washington, D.C. 20460LIST OF ALL REGISTRANTS SENT THIS DATA CALL-IN NOTICECo. Nr.Company NameAgent ForAddressCity & StateZipCase # and Name:0139,Coal Tar/CreosoteKMG-BERNUTH, INC9555 W. SAM HOUSTON PKWY SOUTH, SUITE600HOUSTONTX7709961483